Natzold 5mg Infusion contains zoledronic acid, a bisphosphonate that reduces bone breakdown by inhibiting osteoclast activity.

Mycofit S Tablet contains mycophenolate sodium, an immunosuppressant used to reduce the risk of organ transplant rejection.

Myhep All Tablet contains sofosbuvir and velpatasvir, a direct-acting antiviral combination that inhibits hepatitis C virus replication.

Myfortic 360mg Tablet contains mycophenolate sodium, an immunosuppressive medicine that suppresses immune cell proliferation to prevent transplant rejection.

Myfortic 180mg Tablet contains mycophenolate sodium, an enteric-coated immunosuppressant that prevents rejection following kidney transplantation.

Myelostat 500mg Capsule contains hydroxyurea, an antimetabolite that slows the growth of rapidly dividing cells.

Mycofit S 360mg Tablet contains mycophenolate sodium, an immunosuppressant that suppresses T- and B-lymphocyte proliferation.

Mycofit 500mg Tablet contains mycophenolate mofetil, an immunosuppressive medicine that reduces immune-mediated transplant rejection.

Mycept S 360mg Tablet contains mycophenolate sodium, an enteric-coated immunosuppressant used to prevent organ transplant rejection.

Mycept 500mg Tablet contains mycophenolate mofetil, an immunosuppressant that prevents organ transplant rejection by inhibiting lymphocyte proliferation.

Myaza 100mg Injection contains azacitidine, a hypomethylating agent that slows the growth of abnormal bone marrow cells.

Mozifor 24mg Injection contains plerixafor, a CXCR4 antagonist that mobilises hematopoietic stem cells into the bloodstream for collection.

Mofilet S 360mg Tablet contains mycophenolate sodium, an immunosuppressive medicine that helps prevent rejection following kidney transplantation.

Mofilet 500mg Tablet contains mycophenolate mofetil, an immunosuppressive medicine that prevents immune-mediated organ rejection after transplantation.

Mofetyl S 360mg Tablet contains mycophenolate sodium, an immunosuppressant that inhibits lymphocyte proliferation and reduces transplant rejection.

Mofetyl 500mg Tablet contains mycophenolate mofetil, an immunosuppressant that reduces immune system activity to prevent transplant rejection.

Mofecon S 360mg Tablet contains mycophenolate sodium, an enteric-coated immunosuppressant that helps prevent organ transplant rejection.

Mofecon 500mg Tablet contains mycophenolate mofetil, an immunosuppressive medicine used to prevent rejection following organ transplantation.

Mofecon 250mg Capsule contains mycophenolate mofetil, an immunosuppressant that prevents immune-mediated organ rejection by inhibiting lymphocyte proliferation.

MMF S 360mg Tablet contains mycophenolate sodium, an immunosuppressant that suppresses T and B lymphocyte activity to reduce organ rejection.

MMF 500mg Tablet contains mycophenolate mofetil, an immunosuppressive medicine that helps prevent rejection following organ transplantation.

MMF 500mg Tablet contains mycophenolate mofetil, an immunosuppressant that inhibits lymphocyte proliferation to prevent organ transplant rejection.

Mitotax 250mg Injection contains paclitaxel, a taxane anticancer medicine that inhibits cell division by stabilising microtubules.